Other languages Visioneering Technologies, Inc.

Equities

VTI

AU000000VTI2

Delayed Australian S.E. Other stock markets 20:48:18 2024-05-01 EDT			5-day change	1st Jan Change
0.095 ^AUD	-5.00%		-45.71%	-62.00%

04-24	Transcript : Visioneering Technologies, Inc., Q1 2024 Earnings Call, Apr 23, 2024
02-28	Visioneering Technologies, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Visioneering Technologies, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	02-28
Visioneering Technologies Issues Part of Shortfall from Rights Offering	01-04
VTI gibt positive vorläufige 1-Jahres-Daten aus der klinischen PROTECT-Studie auf der Jahrestagung der American Academy of Optometry bekannt	23-10-12
Visioneering Technologies Raising Funds for Clinical Trial, Business Expansion	23-10-10
Visioneering Technologies, Inc. Announces the Appointment of Juan Carlos Aragón as Chief Executive Officer, Effective 1 October 2023	23-08-28
Visioneering Technologies, Inc. Announces the Appointment of Juan Carlos Aragón as Executive Director, Effective 1 October 2023	23-08-28
Visioneering Technologies, Inc. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-16
Visioneering Technologies, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-02-27
Visioneering Technologies, Inc. Announces Board Changes	22-12-19
Visioneering Technologies, Inc. Enrolls 100% of Subjects in its International Randomized Controlled Clinical Trial Known as PROTECT	22-12-06
Visioneering Technologies, Inc. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-22
Visioneering Technologies Reaches 50% Enrolment Milestone in Nearsightedness Clinical Trial	22-07-12
Visioneering Technologies, Inc. Achieves 50% Enrollment Milestone in its PROTECT International Clinical Study for Myopia Progression Control	22-07-12
Visioneering Technologies, Inc. Announces Board Changes	22-06-29
Visioneering Technologies, Inc. Provides Revenue Guidance for the Year 2022	22-06-02
Visioneering Technologies, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	22-02-23
Visioneering Technologies Enrolls First Patient for Contact Lens Clinical Trial; Shares Rise 3%	22-01-23
Visioneering Technologies, Inc. Announces Initiation of the Protect Clinical Trial	22-01-23
Visioneering Technologies' CEO Resigns	21-12-08
Visioneering Technologies Says Multifocal Contact Lenses Prevents Myopia Progression	21-11-05

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Visioneering Technologies, Inc.

Equities

VTI

AU000000VTI2

Other languages

Filters